BellData Intelligence
Newsroom/Market
Market15h ago

Ebola infections in DR Congo surge to 3,200, with 1,405 deaths

Bell summary

The Democratic Republic of the Congo's 17th Ebola outbreak has infected 3,200 people with 1,405 deaths as of Sunday, surging by approximately 1,000 cases in ten days. The Bundibugyo strain, for which no approved vaccine or treatment exists, has spread across five provinces, with nearly 90 percent of cases concentrated in Ituri province.

The full story

The Ebola outbreak declared in the Democratic Republic of the Congo on May 15 continues to accelerate, with confirmed infections reaching 3,200 and fatalities at 1,405 according to government figures released Sunday. The pace of transmission has intensified markedly, with roughly 1,000 new cases emerging within a single ten-day period, straining containment efforts across multiple regions.

The outbreak is caused by the Bundibugyo strain of Ebola virus, a variant against which no licensed vaccine or approved therapeutic treatment is currently available. The World Health Organization reports that nearly 90 percent of documented cases have occurred in Ituri province in the northeast, which shares borders with South Sudan and Uganda. The virus has now been detected across five provinces, including two regions where transmission has recently emerged.

Logistical and operational challenges are hampering response efforts. According to the UN Humanitarian Air Service, transporting medical personnel and response teams to affected areas remains difficult despite the humanitarian community's commitment to intervention. The service is simultaneously facilitating the movement of samples for laboratory analysis to maintain epidemiological tracking. Healthcare worker strikes over unpaid wages have further disrupted response operations in certain hospital facilities.

Authorities attribute the rising case count partly to enhanced detection and testing capabilities that have improved case identification. The outbreak is expected to persist for several additional months. Meanwhile, the scientific community is accelerating development efforts, with Oxford University reporting that an initial volunteer cohort has received an experimental vaccine targeting the Bundibugyo strain. Multiple additional vaccine candidates are undergoing expedited clinical trial preparation, and two potential therapeutic agents are in development.

Mentioned in this story
World Health OrganizationUN Humanitarian Air ServiceOxford University

Bell tracks these organizations in depth — profiles, people, signals, and history. See them inside Bell →

Written by Bell Data Intelligence · based on reporting by Al Jazeera.Read the original ↗
See what Bell tracks daily

The live signal stream across the Qatari market.

191,000+
Qatari companies
76,000+
actively trading
All
decision-makers